Evaluation and Support Care Process Within the Care Pathway of Heart Failure Patients - Trial NCT04878263
Access comprehensive clinical trial information for NCT04878263 through Pure Global AI's free database. This phase not specified trial is sponsored by Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer and is currently Recruiting. The study focuses on Heart Failure Acute. Target enrollment is 454 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Timeline & Enrollment
N/A
Jun 28, 2021
Dec 27, 2023
Primary Outcome
FIL-EAS ic care pathway safety non inferiority
Summary
Acute heart failure current management turns out to be a relative failure considering its
 elevated economical and human costs and the poor results obtained in terms of disease
 outcome. Indeed this disease remains associated with a high rate of early re-hospitalizations
 and low adherence to therapeutic recommended settings and doses. Moreover, extra
 cardiological follow-up such as in social, geriatric or vaccination fields remain low
 compared to real needs.
 
 Current recommendations incite health professionals to better define care pathways and to
 rationalize resources. Guidelines toward creation of hospitalization alternatives or
 limitation of time spent in hospital are given. In the same time, lack of cardiologic care
 management within heart failure patient care pathway is associated to poor prognosis and
 medical desertification as well as resource concentration on important health centers
 exacerbate this phenomenon. Innovative projects are then needed to improve patient care
 pathways, to open up areas without specialized health professionals and to rationalize care
 management by encouraging communication and skill exchange between hospitals and private
 practices.
 
 FIL-EAS ic projet aims to compare a conventional care pathway in hospital with a follow up
 defined according to High Authority of Health recommendations to an organized care pathway
 favoring a short hospitalization (maximum of 4 working days) with early transition, when
 possible, to a medical and paramedical home care management with an approximately 10 day long
 combined follow up between hospital and private practices. This second care pathway should
 help to optimize therapeutics in home living conditions.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04878263
Non-Device Trial

